X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (30) 30
humans (29) 29
hematology (24) 24
female (18) 18
male (16) 16
adult (14) 14
middle aged (13) 13
aged (11) 11
cancer (10) 10
treatment outcome (10) 10
chemotherapy (9) 9
oncology (9) 9
young adult (9) 9
analysis (8) 8
transplantation (8) 8
aged, 80 and over (7) 7
leukemia (7) 7
mutation (7) 7
acute myeloid-leukemia (6) 6
adolescent (6) 6
remission induction (6) 6
retrospective studies (6) 6
acute myeloid leukemia (5) 5
antineoplastic combined chemotherapy protocols - therapeutic use (5) 5
further section (5) 5
hematopoietic stem cells (5) 5
medical research (5) 5
minimal residual disease (5) 5
prognosis (5) 5
stem-cell transplantation (5) 5
therapy (5) 5
adult patients (4) 4
aml (4) 4
blood (4) 4
bone marrow (4) 4
care and treatment (4) 4
combined modality therapy (4) 4
genetic aspects (4) 4
hematopoietic stem cell transplantation (4) 4
malignant-lymphoma (4) 4
medicine, experimental (4) 4
non-hodgkins-lymphoma (4) 4
patients (4) 4
research (4) 4
risk factors (4) 4
bone marrow - pathology (3) 3
bone marrow transplantation (3) 3
bone-marrow-transplantation (3) 3
child (3) 3
cohort studies (3) 3
cytarabine - administration & dosage (3) 3
disease-free survival (3) 3
flow cytometry (3) 3
immunodeficiency (3) 3
immunology (3) 3
infections (3) 3
leukemia, myeloid, acute - drug therapy (3) 3
leukemia, myeloid, acute - mortality (3) 3
lymphoma, large b-cell, diffuse - pathology (3) 3
lymphomas (3) 3
myelodysplastic syndrome (3) 3
neoplasm staging (3) 3
neutropenia - chemically induced (3) 3
survival rate (3) 3
time factors (3) 3
transplantation, homologous (3) 3
abridged index medicus (2) 2
acute disease (2) 2
acute lymphatic leukemia (2) 2
acute lymphoblastic-leukemia (2) 2
acute lymphocytic leukemia (2) 2
acute myelogenous leukemia (2) 2
adults (2) 2
allogeneic transplantation (2) 2
allografts (2) 2
ambiguous lineage (2) 2
animals (2) 2
antibodies, monoclonal - adverse effects (2) 2
antimetabolites, antineoplastic - administration & dosage (2) 2
antimetabolites, antineoplastic - adverse effects (2) 2
antimetabolites, antineoplastic - therapeutic use (2) 2
antineoplastic agents - adverse effects (2) 2
antineoplastic agents - therapeutic use (2) 2
autoimmune-diseases (2) 2
b-cell (2) 2
b-cell lymphoma (2) 2
b-lymphocytes - pathology (2) 2
biochemistry (2) 2
biomarkers - metabolism (2) 2
biomedicine (2) 2
biphenotypic acute-leukemia (2) 2
case series (2) 2
cell biology (2) 2
child, preschool (2) 2
chronic granulomatous disease (2) 2
clinical characteristics (2) 2
clinical trials (2) 2
complete remission (2) 2
cytarabine - adverse effects (2) 2
cytarabine - therapeutic use (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


European Journal of Clinical Investigation, ISSN 0014-2972, 02/2019, Volume 49, Issue 2, pp. e13047 - n/a
Journal Article
Annals of Hematology, ISSN 0939-5555, 8/2019, Volume 98, Issue 8, pp. 1927 - 1932
Patients with acute myeloid leukemia (AML) who progress after exposure to hypomethylating agents (HMA) have a dismal prognosis. We hypothesized that the... 
Refractory | Medicine & Public Health | Hematology | Hypomethylating agents | Oncology | Acute myeloid leukemia | Venetoclax | AML | DECITABINE | OLDER PATIENTS | AZACITIDINE | HEMATOLOGY | MYELODYSPLASTIC SYNDROME | FAILURE | CARE | Analysis | Oncology, Experimental | Mortality | Resveratrol | Bone marrow | Transplantation | Research | Hematopoietic stem cells | Cancer | Medical prognosis | Leukemia
Journal Article
Acta Haematologica, ISSN 0001-5792, 08/2016, Volume 136, Issue 2, pp. 108 - 117
Journal Article
Journal Article
Clinical Lymphoma Myeloma and Leukemia, ISSN 2152-2650, 09/2017, Volume 17, pp. S284 - S285
Journal Article
European Journal of Clinical Investigation, ISSN 0014-2972, 02/2019, Volume 49, Issue 2, p. e13047
Journal Article
Leukemia & lymphoma, ISSN 1042-8194, 04/2019, pp. 1 - 6
Carbapenem resistant Acinetobacter baumannii (CRAB) is a significant cause of hospital acquired bloodstream infections in patients with hematological... 
Journal Article
Journal Article
European Journal of Haematology, ISSN 0902-4441, 09/2018, Volume 101, Issue 3, pp. 297 - 304
BackgroundMost patients with anemia are diagnosed through clinical phenotype and basic laboratory testing. Nonetheless, in cases of rare congenital anemias,... 
red cell disorders | DYSERYTHROPOIETIC ANEMIA | HEREDITARY STOMATOCYTOSIS | GENE | RECOMMENDATIONS | PIEZO1 | PYRUVATE-KINASE DEFICIENCY | SPLENECTOMY | MUTATIONS | HEMATOLOGY | BONE-MARROW FAILURE | NONSPHEROCYTIC HEMOLYTIC-ANEMIA | Genetic Testing | Anemia - blood | Anemia, Hemolytic, Congenital Nonspherocytic - diagnosis | Humans | Anemia, Dyserythropoietic, Congenital - diagnosis | Child, Preschool | Pyruvate Metabolism, Inborn Errors - genetics | Erythrocyte Indices | Male | Young Adult | Hydrops Fetalis - genetics | Anemia, Sideroblastic - diagnosis | Pyruvate Metabolism, Inborn Errors - diagnosis | Adult | Female | Child | Genetic Predisposition to Disease | Anemia, Dyserythropoietic, Congenital - therapy | Genetic Association Studies | Hydrops Fetalis - diagnosis | Anemia - diagnosis | Anemia, Dyserythropoietic, Congenital - genetics | Computational Biology | Anemia - therapy | Rare Diseases | Anemia, Hemolytic, Congenital - genetics | Pyruvate Kinase - deficiency | Anemia - congenital | Anemia, Sideroblastic - genetics | Anemia, Hemolytic, Congenital - diagnosis | Bone Marrow - pathology | Adolescent | High-Throughput Nucleotide Sequencing | Mutation | Pyruvate Kinase - genetics | Anemia, Hemolytic, Congenital Nonspherocytic - genetics | Anemia | Genetic disorders | Medical genetics | Phenotypes | Genetic counseling | Pyruvate kinase | Pyruvic acid | Sideroblastic anemia | Diagnosis | Kinases | Genetic screening | Index Medicus
Journal Article
Cancer Discovery, ISSN 2159-8274, 04/2016, Volume 6, Issue 4, pp. 368 - 381
Journal Article
British Journal of Clinical Pharmacology, ISSN 0306-5251, 04/2015, Volume 79, Issue 4, pp. 685 - 691
Journal Article
19.